|
|
Volumn 33, Issue 3, 2001, Pages 457-459
|
|
Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
LEVAMISOLE;
RECOMBINANT ALPHA2B INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
IMMUNOLOGICAL ADJUVANT;
ANOREXIA;
ARTICLE;
BONE METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FATALITY;
DRUG RESPONSE;
FOLLOW UP;
HUMAN;
KIDNEY CARCINOMA;
LUNG METASTASIS;
MEDICAL LITERATURE;
MONOTHERAPY;
NEPHRECTOMY;
SELF REPORT;
VOMITING;
ADULT;
AGED;
BONE TUMOR;
DRUG COMBINATION;
EVALUATION;
FEMALE;
KIDNEY TUMOR;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
CARCINOMA, RENAL CELL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMAN;
INTERFERON ALFA-2B;
KIDNEY NEOPLASMS;
LEVAMISOLE;
LUNG NEOPLASMS;
MALE;
MIDDLE AGE;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035545316
PISSN: 03011623
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1019510628249 Document Type: Article |
|
Times cited : (6)
|
|
References (15)
|
